Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 5Recruiting 4Withdrawn 1

Sponsor Class

OTHER 14INDUSTRY 4OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 428Neoplasms 296Breast Neoplasms 296Colorectal Neoplasms 241Neoplasm Metastasis 196Ovarian Neoplasms 171Lung Neoplasms 149Recurrence 148Prostatic Neoplasms 146Pancreatic Neoplasms 141Multiple Myeloma 136Stomach Neoplasms 129Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Leukemia, Myeloid, Acute 115Endometrial Neoplasms 114Advanced Solid Tumors 113Advanced Solid Tumor 108Carcinoma, Hepatocellular 102Triple Negative Breast Neoplasms 101Small Cell Lung Carcinoma 88Uterine Cervical Neoplasms 86Lymphoma, Non-Hodgkin 83Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Hematologic Neoplasms 61

Interventions

spartalizumab 1Interleukin-2 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Drug-Related Side Effects and Adverse Reactions × Clear all
NCT07169851 2026-06-04

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Eli Lilly and Company

Phase 2 Recruiting
204 enrolled

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT07238075 2026-02-17

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

Adcytherix SAS

Phase 1 Recruiting
290 enrolled

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT06716619 2025-03-26

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

Guangzhou FineImmune Biotechnology Co., LTD.

Phase 1 Recruiting
32 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT06302062 2024-12-03

TAL-T

Guangzhou FineImmune Biotechnology Co., LTD.

Phase 1 Recruiting
23 enrolled

Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡